Physiologic estrogen receptor alpha signaling in non-tumorigenic human mammary epithelial cells

作者: Abde M. Abukhdeir , Brian G. Blair , Keith Brenner , Bedri Karakas , Hiroyuki Konishi

DOI: 10.1007/S10549-006-9177-0

关键词:

摘要: Currently, a number of breast cancer cell lines exist that serve as models for both estrogen receptor alpha (ERα) positive and ERα negative disease. Models are also available pre-neoplastic epithelial cells do not express ERα; however, there no ideal systems studying positive. This has been largely due to the inability establish an growth stimulated, non-tumorigenic line, most human engineered overexpress have found be inhibited by estrogens. We developed independently derived clones from non-cancerous MCF-10A line stimulated 17-beta-estradiol (E2) in absence epidermal factor (EGF), cytokine normally required proliferation. effect is blocked selective modulator (SERM), Tamoxifen downregulator, ICI 182,780 (Faslodex, Fulvestrant). Exposure these EGF E2 results inhibitory phenotype similar previous reports. These data present reconciling explanation previously described paradoxical effects overexpression, provide model examining carcinogenic estrogens cells.

参考文章(33)
Gregory S. Schultz, Michael P. LaChance, Susan L. Fitzpatrick, Characterization of epidermal growth factor receptor and action on human breast cancer cells in culture. Cancer Research. ,vol. 44, pp. 3442- 3447 ,(1984)
O. W. Petersen, B. van Deurs, P. E. Høyer, Frequency and distribution of estrogen receptor-positive cells in normal, nonlactating human breast tissue. Cancer Research. ,vol. 47, pp. 5748- 5751 ,(1987)
A. Migliaccio, M. Di Domenico, G. Castoria, A. de Falco, P. Bontempo, E. Nola, F. Auricchio, Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells. The EMBO Journal. ,vol. 15, pp. 1292- 1300 ,(1996) , 10.1002/J.1460-2075.1996.TB00471.X
P. Nangia-Makker, S. R. Wolman, L. Tait, G. H. Heppner, M. P. V. Shekhar, D. W. Visscher, Direct action of estrogen on sequence of progression of human preneoplastic breast disease. American Journal of Pathology. ,vol. 152, pp. 1129- 1132 ,(1998)
Sandra R. Wolman, Herbert D. Soule, Charles M. McGrath, Richard F. Jones, Ward D. Peterson, Jose Russo, S. C. Brooks, Robert J. Pauley, Terry M. Maloney, Richard Brenz, Isolation and Characterization of a Spontaneously Immortalized Human Breast Epithelial Cell Line, MCF-10 Cancer Research. ,vol. 50, pp. 6075- 6086 ,(1990)
Jia‐ling Chou, Zhen Fan, Tony DeBlasio, Andrew Koff, Neal Rosen, John Mendelsohn, Constitutive overexpression of cyclin D1 in human breast epithelial cells does not prevent G1 arrest induced by deprivation of epidermal growth factor. Breast Cancer Research and Treatment. ,vol. 55, pp. 267- 283 ,(1999) , 10.1023/A:1006217413089
E M Gilhooly, D P Rose, The association between a mutated ras gene and cyclooxygenase-2 expression in human breast cancer cell lines. International Journal of Oncology. ,vol. 15, pp. 267- 270 ,(1999) , 10.3892/IJO.15.2.267
Carlos L. Arteaga, Timothy T. Ramsey, Laura K. Shawver, Cheryl A. Guyer, Unliganded Epidermal Growth Factor Receptor Dimerization Induced by Direct Interaction of Quinazolines with the ATP Binding Site Journal of Biological Chemistry. ,vol. 272, pp. 23247- 23254 ,(1997) , 10.1074/JBC.272.37.23247
Christian J Gruber, Doris M Gruber, Isabel M.L Gruber, Fritz Wieser, Johannes C Huber, Anatomy of the estrogen response element Trends in Endocrinology and Metabolism. ,vol. 15, pp. 73- 78 ,(2004) , 10.1016/J.TEM.2004.01.008
Bret B. Friday, Alex A. Adjei, K-ras as a target for cancer therapy. Biochimica et Biophysica Acta. ,vol. 1756, pp. 127- 144 ,(2005) , 10.1016/J.BBCAN.2005.08.001